Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia

Title
Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia
Authors
Keywords
Cerebral ischemia, Cognitive impairment, PI3K/AKT/Nrf2, SLC7A11/GPX4, Oxidative stress, Ferroptosis, Rehmannioside A
Journal
JOURNAL OF ETHNOPHARMACOLOGY
Volume 289, Issue -, Pages 115021
Publisher
Elsevier BV
Online
2022-01-26
DOI
10.1016/j.jep.2022.115021

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started